Science · 2005 · 747 citations · 21 references
Life SciencesImmunologyInfectious DiseasesImmunizationMonoclonal AntibodiesVaccinologyAntibody CharacterizationAntibody-antigen RecognitionAntigen DesignAutoantibodiesHiv Vaccine DevelopmentMolecular MimicryAntibody SubclassesAntibody-mediated Viral NeutralizationAutoantibody AvidityBroadly Neutralizing Antibody InductionBroadly Neutralizing Antigen DesignHiv Envelope Glycoprotein AntigensNeutralizing Antibody ResponsesVaccine Immunogen Design
The design of a human immunodeficiency virus-1 (HIV-1) immunogen that can induce broadly reactive neutralizing antibodies is a major goal of HIV-1 vaccine development. Although rare human monoclonal antibodies (mAbs) exist that broadly neutralize HIV-1, HIV-1 envelope immunogens do not induce these antibody specificities. Here we demonstrate that the two most broadly reactive HIV-1 envelope gp41 human mAbs, 2F5 and 4E10, are polyspecific autoantibodies reactive with the phospholipid cardiolipin. Thus, current HIV-1 vaccines may not induce these types of antibodies because of autoantigen mimicry of the conserved membrane-proximal epitopes of the virus. These results may have important implications for generating effective neutralizing antibody responses by using HIV-1 vaccines.
21
HIV vaccine design and the neutralizing antibody problem
Dennis R. Burton, Ronald C. Desrosiers, Robert W. Doms et al. · Nature Immunology · 2004 · 765 citations